Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Edwards Lifesciences Corporation

Edwards Lifesciences Corporation (EW) Stock Overview

Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.

EW●NYSE
HealthcareMedical - Devices
$85.73
$2.11(2.40%)
U.S. Market opens in 6h 21m

Edwards Lifesciences Corporation (EW)

Meyka AI Score

Z

Key Financials

Market Cap49.4B
P/E Ratio45.49
EPS (TTM)$2.70
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$93.98
3 Months$85.62
1 Year Target$84.70

EW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Edwards Lifesciences Corporation (EW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $84.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 45.49 and a market capitalization of 49.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.40%
5-Day Change
-6.51%
1-Month Change
-1.10%
3-Month Change
5.85%
6-Month Change
1.64%
Year-to-Date (YTD) Change
0.56%
1-Year Change
12.54%
3-Year Change
-7.47%
5-Year Change
-16.69%
All-Time (Max) Change
6134.91%

Contact Information

https://www.edwards.com
949 250 2500
One Edwards Way, Irvine, CA, 92614

Company Facts

160,000 Employees
IPO DateMar 27, 2000
CountryUS
Actively Trading

Frequently Asked Questions